DK1406641T3 - Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme - Google Patents
Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdommeInfo
- Publication number
- DK1406641T3 DK1406641T3 DK02734945T DK02734945T DK1406641T3 DK 1406641 T3 DK1406641 T3 DK 1406641T3 DK 02734945 T DK02734945 T DK 02734945T DK 02734945 T DK02734945 T DK 02734945T DK 1406641 T3 DK1406641 T3 DK 1406641T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- curly
- extracts
- cardiovascular diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29838301P | 2001-06-18 | 2001-06-18 | |
PCT/CA2002/000843 WO2002102394A2 (fr) | 2001-06-18 | 2002-06-07 | Krill et/ou extraits marins pour la prevention et/ou le traitement des maladies cardiovasculaires, de l'arthrite, du cancer de la peau, du diabete, du syndrome premenstruel et du transport transdermique |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1406641T3 true DK1406641T3 (da) | 2009-05-04 |
Family
ID=23150259
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08164524.4T DK1997498T3 (da) | 2001-06-18 | 2002-06-07 | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
DK02734945T DK1406641T3 (da) | 2001-06-18 | 2002-06-07 | Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08164524.4T DK1997498T3 (da) | 2001-06-18 | 2002-06-07 | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
Country Status (14)
Country | Link |
---|---|
US (5) | US20040241249A1 (fr) |
EP (2) | EP1406641B1 (fr) |
JP (4) | JP5135568B2 (fr) |
CN (2) | CN1516592A (fr) |
AT (2) | ATE554779T1 (fr) |
CA (1) | CA2449898C (fr) |
CY (1) | CY1108986T1 (fr) |
DE (1) | DE60230759D1 (fr) |
DK (2) | DK1997498T3 (fr) |
ES (2) | ES2321066T3 (fr) |
HK (2) | HK1126957A1 (fr) |
NO (1) | NO332690B1 (fr) |
PT (1) | PT1406641E (fr) |
WO (1) | WO2002102394A2 (fr) |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60220415T2 (de) | 2001-07-27 | 2008-02-14 | Neptune Technologies & Bioressources Inc., Laval | Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen |
AU2013205514B2 (en) * | 2001-07-27 | 2015-07-02 | Aker Biomarine Antarctic As | Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
NL1022443C2 (nl) | 2003-01-20 | 2004-07-22 | Tno | Sphingolipiden voor verbetering van de samenstelling van de darmflora. |
ES2325260T3 (es) * | 2003-01-20 | 2009-08-31 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Utilizacion de esfingolipidos para reducir los niveles de triacilglicerol y colesterol en el plasma. |
GB0314624D0 (en) | 2003-06-23 | 2003-07-30 | Advanced Bionutrition Europ Lt | Inflammatory disease treatment |
FR2859380B1 (fr) * | 2003-09-05 | 2006-02-10 | Phythea | Composition destinee au traitement cosmetique de la peau d'un etre humain |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
KR101249707B1 (ko) | 2003-10-28 | 2013-04-05 | 에모리 유니버시티 | 투석액 및 이에 관련된 방법과 시스템 |
JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
EP1727882A4 (fr) * | 2004-02-06 | 2008-12-10 | Adrien Beaudoin | Procede pour empecher l'oxydation de lipides dans des huiles animales et vegetales et compositions produites selon ce procede |
ATE500752T1 (de) * | 2004-03-16 | 2011-03-15 | Tno | Verwendung von sphingolipiden bei der behandlung und vorbeugung von typ-2-diabetes mellitus, insulinresistenz und metabolismussyndrom |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
US7666447B2 (en) | 2004-10-08 | 2010-02-23 | Pharmanutrients | Compositions including Krill extracts and conjugated linoleic acid and methods of using same |
JP2008521888A (ja) | 2004-11-30 | 2008-06-26 | ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー | 脂肪症の、又は肝毒性及びその後遺症の治療及び予防におけるスフィンゴ脂質 |
JP2006016408A (ja) * | 2005-06-23 | 2006-01-19 | Yamaha Motor Co Ltd | 血中中性脂肪抑制剤 |
JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
EP1951071A2 (fr) * | 2005-10-18 | 2008-08-06 | Artmed S.r.l. | Compositions nutraceutiques et pharmaceutiques contenant de la choline et pouvant servir d'adjuvants dans la prevention et le traitement des retinopathies et du glaucome |
WO2007080515A1 (fr) * | 2006-01-13 | 2007-07-19 | Aker Biomarine Asa | Extrait de krill prevenant la thrombose |
AU2007213506A1 (en) * | 2006-02-07 | 2007-08-16 | Universitetet I Oslo | Omega 3 |
US20100048704A1 (en) * | 2006-07-14 | 2010-02-25 | Nattopharma Asa | Pharmaceutical and nutraceutical products comprising vitamin k2 |
BRPI0718393A2 (pt) * | 2006-11-03 | 2013-11-26 | Pronova Biopharma Norge As | Álcoois de ácido graxo |
EP2098229A4 (fr) | 2006-12-28 | 2010-03-10 | Suntory Holdings Ltd | Agent de régénération des nerfs |
AU2011213836B2 (en) * | 2007-03-28 | 2013-11-14 | Aker Biomarine Antarctic As | Bioeffective krill oil compositions |
AU2014100737B4 (en) * | 2007-03-28 | 2014-09-25 | Aker Biomarine Antarctic As | Processes and products thereof |
US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
ES2415684T3 (es) | 2007-03-28 | 2013-07-26 | Aker Biomarine As | Composiciones de aceite de kril biológicamente eficaces |
AU2014100741B4 (en) * | 2007-08-29 | 2014-09-11 | Aker Biomarine Antarctic As | Processes and products thereof |
NZ598062A (en) * | 2007-08-29 | 2013-11-29 | Aker Biomarine As | A new method for making krill meal |
AU2012244229B2 (en) * | 2007-08-29 | 2013-11-21 | Aker Biomarine Antarctic As | A new method for making krill meal |
US20100226977A1 (en) * | 2007-08-29 | 2010-09-09 | Aker Biomarine Asa | Low viscosity phospholipid compositions |
US8911888B2 (en) | 2007-12-16 | 2014-12-16 | HGST Netherlands B.V. | Three-dimensional magnetic memory with multi-layer data storage layers |
US8586104B2 (en) * | 2008-04-10 | 2013-11-19 | U.S. Nutraceuticals, LLC | Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use |
CA2724463C (fr) * | 2008-05-15 | 2017-10-03 | Pronova Biopharma Norge As | Procede se rapportant a l'huile de krill |
US9239334B2 (en) * | 2008-09-08 | 2016-01-19 | President And Fellows Of Harvard College | Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status |
US8557297B2 (en) | 2008-09-12 | 2013-10-15 | Olympic Seafood, As | Method for processing crustaceans and products thereof |
DK3238551T3 (da) | 2008-09-12 | 2020-03-02 | Rimfrost Tech As | Proces til reduktion af fluoridindholdet ved fremstilling af proteinøse koncentrater ud fra krill |
US9814256B2 (en) | 2009-09-14 | 2017-11-14 | Rimfrost Technologies As | Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof |
KR101024491B1 (ko) * | 2008-12-31 | 2011-03-31 | 인성실업(주) | 해양 동물로부터 지질을 추출하는 방법 |
US8372812B2 (en) * | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
JP2010241710A (ja) * | 2009-04-02 | 2010-10-28 | Japan Health Science Foundation | Ace2活性誘導剤 |
WO2010118362A1 (fr) | 2009-04-09 | 2010-10-14 | The Regents Of The University Of Colorado, A Body Corporate | Procédés et compositions pour induire une hypertrophie physiologique |
EP2435055A2 (fr) | 2009-05-28 | 2012-04-04 | Aker Biomarine ASA | Procédés d'utilisation de l'huile de krill à des fins de traitement des facteurs de risque associés aux affections métaboliques et obésité |
US9399047B2 (en) | 2009-07-23 | 2016-07-26 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and roe extract |
US9216164B2 (en) | 2009-07-23 | 2015-12-22 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US9402857B2 (en) | 2009-07-23 | 2016-08-02 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin |
US8481072B2 (en) | 2009-07-23 | 2013-07-09 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain |
US20130295171A1 (en) | 2009-07-23 | 2013-11-07 | U.S NUTRACEUTICALS, LLC d/b/a Valensa International | Krill oil and reacted astaxanthin composition and associated method |
US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US9913810B2 (en) | 2009-07-23 | 2018-03-13 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and astaxanthin |
US9238043B2 (en) | 2009-07-23 | 2016-01-19 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using algae based oils |
EP2493478B8 (fr) | 2009-10-29 | 2018-03-28 | Acasti Pharma, Inc. | Compositions de phospholipides thérapeutiques concentrées |
CN102638998B (zh) | 2009-10-30 | 2015-10-07 | 塞拉斯有限责任公司 | 用于获取富含磷脂和中性油脂的磷虾油的无溶剂提取法 |
WO2011060170A1 (fr) * | 2009-11-11 | 2011-05-19 | Dynasep Llc | Procédé de déshydratation à l'acétone à bon rendement énergétique |
US20110117207A1 (en) * | 2009-11-17 | 2011-05-19 | U.S. Nutraceuticals, LLC d/b/a Valensa International State of Incorporation: | Use of eggshell membrane formulations to alleviate joint pain |
US9763897B2 (en) | 2010-04-30 | 2017-09-19 | U.S. Nutraceuticals, LLC | Therapeutic astaxanthin and phospholipid composition and associated method |
WO2011137160A2 (fr) | 2010-04-30 | 2011-11-03 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition et méthode permettant d'améliorer le profil des lipides dans le sang et de réduire éventuellement la peroxydation des lipoprotéines de faible densité (ldl) chez l'homme |
US8663704B2 (en) | 2010-04-30 | 2014-03-04 | U.S. Nutraceuticals, LLC | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans |
JP5271454B2 (ja) * | 2010-09-01 | 2013-08-21 | 日本水産株式会社 | アルコール性障害緩和剤 |
KR20120051458A (ko) * | 2010-11-12 | 2012-05-22 | 주식회사 두산 | 크릴 인지질을 이용하여 아스타잔틴 및 dha- 및/또는 epa-결합된 포스파티딜세린을 함유한 조성물을 제조하는 방법 및 이러한 방법에 의해 제조된 조성물 |
CN102485899A (zh) * | 2010-12-03 | 2012-06-06 | 张永志 | 一种制备富含多不饱和双键脂肪酰基的磷脂酰丝氨酸的高品质南极磷虾油的方法 |
CN102041166B (zh) * | 2011-01-20 | 2012-05-23 | 山东师范大学 | 从南极磷虾中提取高磷脂含量的虾油的方法 |
WO2012103685A1 (fr) * | 2011-02-01 | 2012-08-09 | Nippon Suisan Kaisha, Ltd. | Agent d'amélioration de la fonction sexuelle |
KR101045258B1 (ko) * | 2011-02-11 | 2011-06-30 | 대덕에프알디(주) | 크릴 오일 제조 방법 및 상기 방법에 의해 제조된 크릴 오일 |
US20120231087A1 (en) * | 2011-03-07 | 2012-09-13 | Olympic Seafood | Compositions And Methods for Nutritional Supplementation |
ES2643843T3 (es) * | 2011-06-15 | 2017-11-24 | Stable Solutions Llc | Aplicación terapéutica de aceite de kril por vía parenteral |
US10052352B2 (en) | 2011-06-15 | 2018-08-21 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
AU2012272652B2 (en) * | 2011-06-24 | 2017-06-01 | Epitogenesis Inc. | Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
JP6067558B2 (ja) * | 2011-06-29 | 2017-01-25 | 日本水産株式会社 | 恐怖記憶の軽減方法 |
US8846604B2 (en) | 2011-09-02 | 2014-09-30 | Artic Nutrition AS | Lipid compositions with high DHA content |
PL2800563T3 (pl) | 2012-01-06 | 2018-12-31 | Omthera Pharmaceuticals Inc. | Wzbogacone w DPA kompozycje wielonienasyconych kwasów tłuszczowych omega-3 w postaci wolnego kwasu |
CN102559371B (zh) * | 2012-02-21 | 2013-09-18 | 山东师范大学 | 一种制备富含磷脂酰丝氨酸的虾油的方法 |
JP6173437B2 (ja) | 2012-05-07 | 2017-08-02 | オムセラ・ファーマシューティカルズ・インコーポレイテッド | スタチン及びω−3脂肪酸の組成物 |
JP5969616B2 (ja) | 2012-09-07 | 2016-08-17 | 国立研究開発法人科学技術振興機構 | ゲスト化合物内包高分子金属錯体結晶、その製造方法、結晶構造解析用試料の作製方法、及び有機化合物の分子構造決定方法 |
US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
CN102899162B (zh) * | 2012-10-25 | 2013-12-04 | 山东师范大学 | 一种制备低氟含量的南极磷虾虾油的工艺 |
CN102899163B (zh) * | 2012-10-25 | 2015-03-25 | 山东师范大学 | 一种从南极磷虾中提取无氟虾油的工艺 |
CN102925284B (zh) * | 2012-10-25 | 2014-01-08 | 山东师范大学 | 一种从南极磷虾中提取低胆固醇含量的虾油的工艺 |
CN102899164B (zh) * | 2012-10-25 | 2015-12-02 | 山东师范大学 | 一种制备无氟南极磷虾虾油的工艺 |
CN102911786B (zh) * | 2012-10-25 | 2014-01-08 | 山东师范大学 | 一种从南极磷虾中提取低氟含量的虾油的工艺 |
US10123986B2 (en) | 2012-12-24 | 2018-11-13 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US9629820B2 (en) | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
WO2014184655A1 (fr) | 2013-02-07 | 2014-11-20 | Olympic Seafood As | Procédés d'utilisation de complexes phospholipide-peptide-protéine de crustacés |
AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
KR101948398B1 (ko) | 2013-10-08 | 2019-02-14 | 타이요 카가꾸 가부시키가이샤 | 다가 불포화 지방산 함유 유지 조성물 |
JP6393501B2 (ja) * | 2014-04-03 | 2018-09-19 | 太陽化学株式会社 | 多価不飽和脂肪酸含有油脂の風味改善剤 |
JP2015096488A (ja) * | 2013-10-10 | 2015-05-21 | 康二 嘉島 | 終末糖化物質生成抑制方法 |
GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
WO2015142702A1 (fr) | 2014-03-18 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition et procédé pour soulager les douleurs articulaires au moyen de phospholipides et d'extrait d'œufs de poisson |
DE212015000076U1 (de) | 2014-03-18 | 2016-12-06 | U.S. Nutraceuticals Llc Dba Valensa International | Zusammensetzung zum Mildern von Gelenkschmerzen mittels niedermolekulargewichtiger Hyaluronsäure und Astaxanthin |
WO2015142700A1 (fr) | 2014-03-18 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition et procédé destinés à atténuer la douleur articulaire au moyen de phospholipides et d'astaxanthine |
WO2015142999A1 (fr) | 2014-03-19 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition et procédé pour améliorer les profils lipidiques sanguins et réduire la peroxydation des lipoprotéines basse densité (ldl) chez les humains au moyen d'huiles à base d'algues et d'astaxanthine |
WO2015181640A1 (fr) * | 2014-04-30 | 2015-12-03 | Enzymotec Ltd. | Préparations d'huile de krill et leurs utilisations |
JP6299689B2 (ja) * | 2014-07-24 | 2018-03-28 | 三生医薬株式会社 | 生体吸収促進剤含有組成物 |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
AU2015339576B2 (en) | 2014-10-27 | 2020-02-06 | Aseko, Inc. | Subcutaneous outpatient management |
RU2718983C2 (ru) | 2015-02-11 | 2020-04-15 | Акер Биомарин Антарктик Ас | Композиции липидов |
EP3256003B1 (fr) | 2015-02-11 | 2022-11-09 | Aker Biomarine Antarctic AS | Procédés d'extraction de lipides |
US10328105B2 (en) | 2015-05-27 | 2019-06-25 | Rimfrost Technologies As | Flowable concentrated phospholipid krill oil composition |
EP3337402A4 (fr) | 2015-08-20 | 2019-04-24 | Aseko, Inc. | Conseiller de thérapie pour la gestion du diabète |
CN105341184A (zh) * | 2015-10-14 | 2016-02-24 | 中国农业科学院油料作物研究所 | 一种具有预防心脑血管疾病和糖尿病风险因子作用的功能性油脂组合物 |
PT3389407T (pt) | 2015-12-14 | 2024-01-19 | Nestle Sa | Composição nutricional e fórmula para lactentes para promover mielinização de novo |
DE202015106826U1 (de) * | 2015-12-15 | 2016-02-03 | Wolfgang Braun | Zusammensetzung zur Behandlung von Prämenstruellem Syndrom |
BR112018077350A2 (pt) | 2016-06-29 | 2019-04-09 | Machavert Pharmaceuticals Llc | composições de fosfolipídio |
CA3042592A1 (fr) * | 2016-11-04 | 2018-05-11 | Immd Sp. Zo.O | Administration intelligente de molecules ingerees et absorbees |
JP7309136B2 (ja) * | 2017-04-14 | 2023-07-18 | 学校法人帝京大学 | Hdl機能改善剤及びhdl機能改善食品組成物 |
DK3727404T3 (da) * | 2017-12-22 | 2023-10-09 | Pharmalink International Ltd | Sammensætninger omfattende muslingelipidekstrakt og krillolie, og deres medicinske anvendelser |
EP3796898A1 (fr) | 2018-05-24 | 2021-03-31 | U.S. Nutraceuticals, LLC d/b/a Valensa International | Composition et procédé pour soulager les douleurs articulaires au moyen d'acide hyaluronique et de composants de membrane de coquille d' uf |
JP2019210239A (ja) * | 2018-06-02 | 2019-12-12 | 学校法人 岩手医科大学 | 8−ヒドロキシエイコサペンタエン酸の薬理用途 |
DE202018105422U1 (de) | 2018-06-21 | 2018-10-19 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten |
US20220265291A9 (en) * | 2018-06-28 | 2022-08-25 | Marizyme, Inc. | Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices |
CN112638289A (zh) * | 2018-06-28 | 2021-04-09 | 玛利塞生物技术公司 | 治疗血栓形成的药物组合物和方法以及医疗设备递送 |
KR102085506B1 (ko) * | 2018-07-25 | 2020-03-05 | 이경희 | 두피자극완화용 염모제 첨가조성물 및 두피자극완화용 염모제 |
EP4087582A1 (fr) * | 2020-01-10 | 2022-11-16 | Acasti Pharma Inc. | Composition favorisant des médiateurs pro-résolution |
IT202000003964A1 (it) * | 2020-02-26 | 2021-08-26 | Umberto Cornelli | Composizione farmaceutica per l’uso nel trattamento di dismenorrea e/o sindrome premestruale |
KR102451162B1 (ko) * | 2020-09-07 | 2022-10-06 | (주)에스디생명공학 | 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물 |
CN112315984B (zh) * | 2020-09-09 | 2023-02-14 | 山东省科学院生物研究所 | 海洋来源磷脂在促进血管生成方面的应用 |
CN112494499B (zh) * | 2020-12-14 | 2022-01-28 | 山东省科学院生物研究所 | 海洋磷脂作为有效成分在制备预防和/或治疗心脏疾病药物中的应用 |
AU2022224703A1 (en) * | 2021-09-28 | 2023-04-13 | Samuel L. Shepherd | Tetraterpenes for use in cancer therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54119017A (en) * | 1978-03-06 | 1979-09-14 | Taiyo Fishery Co Ltd | Protective agent for hypertensive disease and production |
JPS60153779A (ja) | 1984-01-24 | 1985-08-13 | Hohnen Oil Co Ltd | 栄養補助食品 |
JPS6130527A (ja) * | 1984-07-20 | 1986-02-12 | Kao Corp | 血栓溶解剤 |
JPS61118318A (ja) * | 1984-11-12 | 1986-06-05 | Pola Chem Ind Inc | 血清脂質改善用組成物 |
JPS63295698A (ja) * | 1987-05-27 | 1988-12-02 | Showa Denko Kk | α−リノレン酸の分離精製法 |
US4843095A (en) * | 1987-08-07 | 1989-06-27 | Century Laboratories, Inc. | Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis |
JPH01137952A (ja) * | 1987-11-20 | 1989-05-30 | Nippon Suisan Kaisha Ltd | 健康食品 |
JPH02167055A (ja) * | 1988-12-19 | 1990-06-27 | Seiji Nojima | 機能性練製品 |
JPH03123470A (ja) * | 1989-10-05 | 1991-05-27 | Taiyo Fishery Co Ltd | オキアミ中のアンジオテンシン変換酵素阻害活性の増強法 |
JP2558050B2 (ja) * | 1993-02-18 | 1996-11-27 | イセ食品株式会社 | 鶏用飼料 |
JPH08219A (ja) * | 1994-06-15 | 1996-01-09 | Nippon Synthetic Chem Ind Co Ltd:The | 機能の改善された油組成物 |
JP2666179B2 (ja) * | 1994-08-10 | 1997-10-22 | 財団法人韓國食品開發研究院 | 抗高血圧健康食品組成物 |
JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
JP3664814B2 (ja) * | 1996-06-26 | 2005-06-29 | 旭化成ケミカルズ株式会社 | 血中脂質改善剤及び食品添加剤 |
JP3118556B2 (ja) * | 1996-09-27 | 2000-12-18 | 中央水産研究所長 | 魚肉水溶性タンパク質により油脂を高濃度に含有させた魚肉乳化すり身及びその製造法 |
CA2251265A1 (fr) * | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Procede d'extraction des lipides de tissus d'animaux aquatiques produisant un residu deshydrate |
-
2002
- 2002-06-07 ES ES02734945T patent/ES2321066T3/es not_active Expired - Lifetime
- 2002-06-07 CN CNA028121813A patent/CN1516592A/zh active Pending
- 2002-06-07 WO PCT/CA2002/000843 patent/WO2002102394A2/fr active Application Filing
- 2002-06-07 EP EP02734945A patent/EP1406641B1/fr not_active Expired - Lifetime
- 2002-06-07 DK DK08164524.4T patent/DK1997498T3/da active
- 2002-06-07 AT AT08164524T patent/ATE554779T1/de active
- 2002-06-07 DK DK02734945T patent/DK1406641T3/da active
- 2002-06-07 JP JP2003504980A patent/JP5135568B2/ja not_active Expired - Lifetime
- 2002-06-07 ES ES08164524T patent/ES2386841T3/es not_active Expired - Lifetime
- 2002-06-07 PT PT02734945T patent/PT1406641E/pt unknown
- 2002-06-07 CA CA2449898A patent/CA2449898C/fr not_active Expired - Lifetime
- 2002-06-07 DE DE60230759T patent/DE60230759D1/de not_active Expired - Lifetime
- 2002-06-07 US US10/481,040 patent/US20040241249A1/en not_active Abandoned
- 2002-06-07 AT AT02734945T patent/ATE419858T1/de active
- 2002-06-07 CN CN201110219831.4A patent/CN102319266B/zh not_active Expired - Lifetime
- 2002-06-07 EP EP08164524A patent/EP1997498B1/fr not_active Revoked
-
2003
- 2003-12-16 NO NO20035618A patent/NO332690B1/no not_active IP Right Cessation
-
2006
- 2006-12-18 US US11/640,235 patent/US8057825B2/en not_active Expired - Fee Related
-
2009
- 2009-04-06 CY CY20091100401T patent/CY1108986T1/el unknown
- 2009-05-29 HK HK09104847.8A patent/HK1126957A1/xx not_active IP Right Cessation
- 2009-12-04 JP JP2009276478A patent/JP2010090140A/ja active Pending
- 2009-12-04 JP JP2009276479A patent/JP5228185B2/ja not_active Expired - Lifetime
-
2011
- 2011-08-24 US US13/216,694 patent/US20110305771A1/en not_active Abandoned
-
2012
- 2012-07-04 HK HK12106558.7A patent/HK1165729A1/xx not_active IP Right Cessation
-
2013
- 2013-01-08 JP JP2013001424A patent/JP2013079278A/ja active Pending
-
2014
- 2014-01-10 US US14/152,603 patent/US20140199414A1/en not_active Abandoned
-
2016
- 2016-09-16 US US15/267,988 patent/US20170224742A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1406641T3 (da) | Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme | |
BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
NO20065227L (no) | Menoklonale antistoff mot hepatocytt vekstfaktor | |
DE60236646D1 (de) | Anti-VEGF-2 Antikörper | |
ATE450269T1 (de) | Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten | |
NO20034549D0 (no) | Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV | |
CY1111359T1 (el) | Μεμαντινη για την θεραπεια ηπιας εως μετριας ασθενειας alzheimer | |
ATE433989T1 (de) | Pharmazeutisch wirksame uridinester | |
BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
ATE438618T1 (de) | Inhibitoren von humanem adam-10 | |
WO2002066062A3 (fr) | Renforcement de l'activite de glp-2 | |
BR0201862A (pt) | Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos | |
EA200601238A1 (ru) | Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела | |
WO2004110373A3 (fr) | Compositions vaccinales therapeutiques servant a traiter le diabete de type 1 | |
WO2006109170A3 (fr) | Polytherapie destinee au traitement de maladies cardiovasculaires et de pathologies associees | |
DK1073436T3 (da) | Forbedret fremgangsmåde til udryddelse af helicobacter pylori | |
ATE326226T1 (de) | Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen | |
IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. | |
NO20041955L (no) | Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte | |
DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
ATE398134T1 (de) | Neue analoga von nitrobenzylthioinosin | |
EA200401147A1 (ru) | Циталопрам для лечения повышенного кровяного давления | |
WO2003101988A3 (fr) | Composes et compositions de traitement du diabete et des troubles associes au diabete | |
AU2002311125A1 (en) | Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |